Maxcyte MXCT
NASDAQ MXCT
$1.38 -0.01 (-0.72%)
At close: Aug 20, 2026 · 1:46 PM UTC

Maxcyte (MXCT) Acquisitions (2025)

Maxcyte (MXCT) posted quarterly Acquisitions of $1.8 million for Q1 2025.

Maxcyte (MXCT) Acquisitions (2025) Analysis & Trends

Maxcyte (MXCT) has reported Acquisitions for 1 consecutive years, with $1.8 million the latest figure, recorded in Q1 2025.

  • In Q1 2025, Acquisitions changed N/A year-over-year to $1.8 million; the TTM figure through Dec 2025 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
  • Acquisitions steadied at $1.8 million in Q1 2025 per MXCT's latest filing.
  • Across five years, Acquisitions topped out at $1.8 million in Q1 2025 and bottomed at $1.8 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 198.95 Bn 193.34 Bn 7.27 Bn -
2 Stryker 127.40 Bn 123.93 Bn 4.50 Bn 437.00 Mn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn 406.00 Mn
4 Boston Scientific 73.24 Bn 72.71 Bn 3.85 Bn -
5 Edwards Lifesciences 51.95 Bn 47.70 Bn 1.35 Bn -
6 Dexcom 34.39 Bn 32.44 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.87 Bn 31.76 Bn 2.18 Bn -4.00 Mn
8 Koninklijke Philips 26.34 Bn 23.02 Bn 4.55 Bn -3.49 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 16.00 Mn
10 Maxcyte 147.42 Mn 147.42 Mn 5.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.77 Mn